The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Al-tarafi, Issam Adil
    Director born in May 1975
    Individual (8 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
  • 2
    Mcananey, Stephen Peter
    Company Director born in June 1979
    Individual (3 offsprings)
    Officer
    2020-02-26 ~ now
    OF - Director → CIF 0
    Mr Stephen Peter Mcananey
    Born in June 1979
    Individual (3 offsprings)
    Person with significant control
    2020-02-26 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Lamport-went, Steven James
    Director born in April 1964
    Individual (9 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
    Lamport-went, Steven James
    Individual (9 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Secretary → CIF 0
Ceased 4
  • 1
    Lynam, Colin John
    Director born in December 1982
    Individual (1 offspring)
    Officer
    2017-09-29 ~ 2018-02-21
    OF - Director → CIF 0
    Lynam, Colin John
    Company Director born in December 1982
    Individual (1 offspring)
    2020-02-26 ~ 2025-01-31
    OF - Director → CIF 0
  • 2
    Mr Issam Adil Al-tarafi
    Born in May 1975
    Individual (8 offsprings)
    Person with significant control
    2017-09-29 ~ 2022-04-05
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Mcananey, Stephen Peter
    Director born in June 1979
    Individual (3 offsprings)
    Officer
    2017-09-29 ~ 2018-02-21
    OF - Director → CIF 0
  • 4
    Mr Steven James Lamport-went
    Born in April 1964
    Individual (9 offsprings)
    Person with significant control
    2017-09-29 ~ 2022-04-05
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

I-PHARM CONSULTING GROUP LIMITED

Standard Industrial Classification
78200 - Temporary Employment Agency Activities
Brief company account
Fixed Assets - Investments
230,000 GBP2023-12-31
230,000 GBP2022-12-31
Debtors
52,000 GBP2023-12-31
52,000 GBP2022-12-31
Equity
Called up share capital
1,000 GBP2023-12-31
1,000 GBP2022-12-31
1,000 GBP2021-12-31
Share premium
207,000 GBP2023-12-31
207,000 GBP2022-12-31
207,000 GBP2021-12-31
Retained earnings (accumulated losses)
0 GBP2023-12-31
0 GBP2022-12-31
0 GBP2021-12-31
Profit/Loss
490,000 GBP2023-01-01 ~ 2023-12-31
499,000 GBP2022-01-01 ~ 2022-12-31
Equity
208,000 GBP2023-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Wages/Salaries
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Investments in Subsidiaries
230,000 GBP2023-12-31
230,000 GBP2022-12-31
Trade Debtors/Trade Receivables
0 GBP2023-12-31
0 GBP2022-12-31
Amount of corporation tax that is recoverable
0 GBP2023-12-31
0 GBP2022-12-31
Other Debtors
Current
0 GBP2023-12-31
0 GBP2022-12-31
Prepayments/Accrued Income
Current
0 GBP2023-12-31
0 GBP2022-12-31
Corporation Tax Payable
Current
0 GBP2023-12-31
0 GBP2022-12-31

Related profiles found in government register
  • I-PHARM CONSULTING GROUP LIMITED
    Info
    Registered number 10988701
    Moor Place, 1 Fore Street Avenue, Fore Street Avenue, London EC2Y 9DT
    Private Limited Company incorporated on 2017-09-29 (7 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-18
    CIF 0
  • I-PHARM CONSULTING GROUP LIMITED
    S
    Registered number 10988701
    Moor Place, 1 Fore Street Avenue, Fore Street Avenue, London, United Kingdom, EC2Y 9DT
    Limited Company in Companies House, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • Moor Place, 1 Fore Street Avenue, London, England
    Active Corporate (4 parents, 3 offsprings)
    Equity (Company account)
    4,009,194 GBP2023-12-31
    Person with significant control
    2018-03-07 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
    CIF 1 - Right to appoint or remove directorsOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.